DE LEO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 9.446
NA - Nord America 5.624
EU - Europa 5.357
AF - Africa 615
SA - Sud America 495
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 21.551
Nazione #
US - Stati Uniti d'America 5.512
VN - Vietnam 3.179
IT - Italia 2.304
SG - Singapore 2.261
CN - Cina 2.091
HK - Hong Kong 572
DE - Germania 524
SE - Svezia 441
GB - Regno Unito 386
BR - Brasile 370
KR - Corea 329
NL - Olanda 322
IN - India 306
FR - Francia 267
FI - Finlandia 188
CI - Costa d'Avorio 182
IE - Irlanda 176
RU - Federazione Russa 155
JP - Giappone 135
SC - Seychelles 135
TG - Togo 117
CH - Svizzera 116
AT - Austria 83
ID - Indonesia 83
CA - Canada 79
PH - Filippine 76
PL - Polonia 74
JO - Giordania 73
ZA - Sudafrica 67
BG - Bulgaria 61
BD - Bangladesh 57
AR - Argentina 55
ES - Italia 48
NG - Nigeria 44
IQ - Iraq 42
PK - Pakistan 40
TH - Thailandia 39
TR - Turchia 36
UA - Ucraina 32
TW - Taiwan 29
BE - Belgio 26
MX - Messico 23
SK - Slovacchia (Repubblica Slovacca) 21
EC - Ecuador 19
SA - Arabia Saudita 19
CZ - Repubblica Ceca 16
DZ - Algeria 16
IR - Iran 16
LT - Lituania 15
UZ - Uzbekistan 15
GR - Grecia 14
VE - Venezuela 14
CL - Cile 13
MK - Macedonia 13
EE - Estonia 12
AU - Australia 11
KE - Kenya 9
DK - Danimarca 8
HR - Croazia 8
MY - Malesia 8
NO - Norvegia 8
PT - Portogallo 8
RO - Romania 8
CO - Colombia 7
OM - Oman 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
AL - Albania 5
AZ - Azerbaigian 5
TN - Tunisia 5
AO - Angola 4
EG - Egitto 4
GH - Ghana 4
RS - Serbia 4
UG - Uganda 4
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
ML - Mali 3
NP - Nepal 3
SI - Slovenia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
Totale 21.533
Città #
Singapore 1.552
Ho Chi Minh City 895
Ashburn 894
Bologna 761
Hanoi 727
Hefei 651
Hong Kong 533
San Jose 403
Chandler 383
Seoul 301
Santa Clara 272
Southend 256
Dallas 243
Beijing 224
Fairfield 205
Council Bluffs 187
Abidjan 182
Dublin 174
Boardman 151
Milan 149
Los Angeles 143
Helsinki 140
Princeton 140
Da Nang 135
Tokyo 119
Lauterbourg 117
Lomé 117
Haiphong 112
Redmond 112
Seattle 110
New York 109
Bern 104
Houston 94
Wilmington 82
Woodbridge 80
Frankfurt am Main 75
Turin 75
Amman 73
Munich 66
Warsaw 65
Amsterdam 61
Sofia 61
Bengaluru 59
Buffalo 59
Cambridge 58
Redondo Beach 58
Vienna 58
Rome 57
Florence 54
Jakarta 52
Berlin 49
Hyderabad 45
Thái Nguyên 43
Groningen 42
Guangzhou 42
São Paulo 42
Ann Arbor 40
Biên Hòa 40
Quận Bình Thạnh 39
Shanghai 39
Hải Dương 38
Johannesburg 38
Abeokuta 37
Rimini 37
Can Tho 36
Nuremberg 36
Chicago 35
Bremen 32
Des Moines 30
Dong Ket 30
Hangzhou 30
Lappeenranta 30
Montreal 30
Ninh Bình 30
Bến Tre 29
London 29
Modena 29
Orem 28
Shenzhen 27
The Dalles 27
Vũng Tàu 27
Falkenstein 26
San Diego 26
Ha Long 25
Phủ Lý 25
Thái Bình 25
Verona 23
Atlanta 22
Nanjing 22
Nha Trang 22
Paris 22
Ravenna 22
Westminster 22
Bratislava 21
Bắc Giang 21
Tongling 21
Toronto 21
Baghdad 20
Forlì 20
Padova 20
Totale 13.300
Nome #
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 432
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 345
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 331
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 299
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 298
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 292
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 278
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 269
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 264
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 255
An analysis of clinical, surgical, pathological and molecular characteristics of endometrial cancer according to mismatch repair status. A multidisciplinary approach 245
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 243
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 243
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review 243
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 240
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 239
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 233
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 232
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 231
Classification systems of endometrial cancer: A comparative study about old and new 227
Next-generation technologies in predictive molecular pathology of lung cancers 222
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 220
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 219
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 217
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 216
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 207
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation. 206
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 204
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 199
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma 197
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 197
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy 195
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 193
Relevance of ARID1A Mutations in Endometrial Carcinomas 193
Sclerosing Angiomatoid Nodular Transformation of the Adrenal Gland: A Case Report of a Novel Histopathological Entity 192
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms 189
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 189
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 188
Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers 184
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 180
The diagnostic dilemma of adrenal vascular tumors: analysis of 21 cases and systematic review of the literature 176
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment 172
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 172
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 171
Can we improve the diagnosis of invasion in encapsulated follicular-patterned thyroid tumors? Data from a massive international e-learning initiative 170
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients 167
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 167
Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma 166
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 166
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 166
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 166
Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center 164
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 164
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH 164
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 163
Analysis of HNF1β expression suggests that its downregulation is involved in the sarcomatoid transformation of yolk sac tumor 163
Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients 162
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 162
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 160
HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas 159
Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity 157
Robbins e Cotran Le basi patologiche delle malattie. Capitolo 23 ''La mammella''. 155
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 155
DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas 154
An exceptional case of primary ovarian angiosarcoma 153
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 152
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma 150
Uterine preservation treatments in sarcomas: Oncological problems and reproductive results: A systematic review 147
Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel 145
A Radiomic-Based Machine Learning Model Predicts Endometrial Cancer Recurrence Using Preoperative CT Radiomic Features: A Pilot Study 144
Molecular Diagnosis of Peripheral T-Cell Lymphoma/NOS From Formalin Fixed Paraffin Embedded Tissues. 143
Characterization of BRCA Deficiency in Ovarian Cancer 143
Prognostic Evaluation of Localized Primary Gastrointestinal Stromal Tumors (GIST): Comparison between Risk Classification Systems and Role of Mutational Analysis in a Single Unit Experience 142
Gene expression landscape of sdh-deficient gastrointestinal stromal tumors 142
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 141
Granular cell tumour of the breast: A rare presentation of a breast mass in an elderly female with a subsequent breast cancer diagnosis 141
Integrated clinicopathological and molecular analysis of endometrial carcinoma: prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification 140
Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study 138
Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis 136
Radiomics and artificial intelligence in uterine sarcomas: A systematic review 133
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes 132
Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience. 128
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel 126
Identification of Differentially Expressed miRNAs in Peripheral t-Cell Lymphomas. 125
Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma? 125
Endometrial carcinoma: Past, present, and future 125
Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter 123
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel 117
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST 115
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 115
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 7: Pd-l1 expression in liquid biopsy 114
Diagnostic Feasibility and Accuracy of Endoscopic Ultrasound-Guided Fine Needle Core Biopsy (EUS-FNB): A Single-Center Large Cohort Study 111
Ovarian Neuroendocrine Tumors: Pathological and Immunohistochemical Features of a Single- Center Case Series 110
CORRELATION BETWEEN CLINICAL (Cl-R) AND PATHOLOGICAL RESPONSE (Pt-R) AFTER NEO-ADJUVANT ELECTROCHEMOTHERAPY (ECT) IN VULVAR SQUAMOUS CELL CARCINOMA(V-SCC) 109
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance 109
Molecular alterations in pancreatic tumors 107
Solid Variant of Adenoid Cystic Carcinoma of the Breast: A Case Series with Proposal of a New Grading System 106
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region 105
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis 100
A clinically applicable integrated molecular, immunohistochemical and histological approach for endometrial carcinoma. 99
Totale 17.978
Categoria #
all - tutte 59.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021277 0 0 0 0 0 0 0 0 0 68 43 166
2021/20221.359 41 30 47 96 131 78 39 136 111 112 349 189
2022/20232.586 150 251 152 260 203 224 90 170 475 109 227 275
2023/20241.110 111 111 59 92 106 185 60 87 62 78 55 104
2024/20254.182 267 408 373 290 472 207 315 192 104 349 384 821
2025/202611.277 1.892 1.197 1.093 926 893 482 1.457 357 2.234 746 0 0
Totale 21.998